EMH.V - Emerald Health Therapeutics, Inc.

TSXV - TSXV Delayed Price. Currency in CAD
3.6600
-0.0400 (-1.08%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.7000
Open3.6300
Bid3.6400 x 0
Ask3.6900 x 0
Day's Range3.6300 - 3.7200
52 Week Range2.0400 - 5.9200
Volume307,330
Avg. Volume783,382
Market Cap526.795M
Beta (3Y Monthly)2.17
PE Ratio (TTM)N/A
EPS (TTM)-0.2160
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.10
  • PR Newswire2 days ago

    Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...

  • GlobeNewswire2 days ago

    Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

    VANCOUVER, British Columbia, May 17, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 6,000 40 ml units of its SYNC 25 CBD oil to the.

  • GlobeNewswire4 days ago

    Emerald Health Therapeutics to Participate in Cowen Toronto Cannabis Summit

    VANCOUVER, British Columbia, May 15, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in Cowen’s Toronto Cannabis Summit on May.

  • CNW Group5 days ago

    Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

    Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

  • GlobeNewswire5 days ago

    Emerald Health Therapeutics Expands Adult-Use Cannabis Distribution to Additional Provinces

    OTCQX: EMHTF) has been authorized by PEI Cannabis and Manitoba Liquor & Lotteries Corporation to supply Emerald-branded cannabis products into those provinces. “We are pleased to have the opportunity to serve additional provinces,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. Emerald’s cannabis supply is provided by its Verdélite indoor facility in Québec and Pure Sunfarms, its 50%-owned joint venture in British Columbia that is fully planted in its 1.03 million square foot greenhouse growing area.

  • Cannabis Sector Weekly Update: Sell-Off amid Market Weakness
    Market Realist6 days ago

    Cannabis Sector Weekly Update: Sell-Off amid Market Weakness

    Cannabis Sector Weekly Update: Sell-Off amid Market WeaknessCannabis weekly updateLast week, cannabis ETFs fell for the second consecutive week. The Horizons Marijuana Life Sciences ETF (HMMJ) saw a negative price action of 3.1%, while the ETFMG

  • Key Cannabis Sector Updates: Analyst Ratings and Earnings
    Market Realist12 days ago

    Key Cannabis Sector Updates: Analyst Ratings and Earnings

    Key Cannabis Sector Updates: Price Action and Analyst Ratings(Continued from Prior Part)Cannabis updateLast week, Emerald Health Therapeutics (EMH) closed with losses of 9.4%. The company released its fourth-quarter and full-year 2018 earnings last

  • GlobeNewswire18 days ago

    Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Growth in Q1 2019

    VANCOUVER, British Columbia, May 01, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the fourth quarter and.

  • GlobeNewswire18 days ago

    Emerald to Issue Shares in lieu of Cash due under for Verdélite Acquisition

    Emerald Health Therapeutics, Inc. (EMH.V) (“Emerald” or the “Company”) today announced that the vendors (the "Vendors") of Verdélite Sciences, Inc. and Verdélite Property Holdings, Inc. (collectively, "Verdélite") have elected to receive $7.5 million of the $22.5 million they were to receive as the final payment for their shares of Verdélite in shares of Emerald valued on the five-day volume-weighted average price of the common shares of Emerald on the TSX Venture Exchange, discounted 10%, calculated as of April 30, 2019. See the Company's news release dated May 2, 2018 for more details on the Verdélite acquisition.  Emerald is to pay the remaining $15 million of the purchase price to the Vendors on or before May 30, 2019.

  • Cannabis Sector: Analysts’ Ratings and Analysis
    Market Realist20 days ago

    Cannabis Sector: Analysts’ Ratings and Analysis

    Cannabis Updates: Price Action, Ratings, and More(Continued from Prior Part)Cannabis sectorLast week, Benchmark initiated coverage on Charlotte’s Web Holdings (CWBHF) (CWEB) with a “buy” rating and a $25 price target. The stock has received

  • Ups and Downs in the Cannabis Space Last Week
    Market Realist20 days ago

    Ups and Downs in the Cannabis Space Last Week

    Cannabis Updates: Price Action, Ratings, and MoreCannabis spaceThe cannabis space was mostly positive last week. The Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternate Harvest ETF (MJ) gained 5.2% and 4.2%, respectively, while the

  • GlobeNewswire26 days ago

    Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse is Fully Planted; Reporting Year End Financials May 1st

    OTCQX: EMHTF) today announced that its 50%-owned joint venture, Pure Sunfarms, has completed planting of the final quadrants of its 1.1 million square foot Delta 3 greenhouse operation in Delta, BC.  As a result, the entire 1.03 million square feet of growing area at Delta 3, comprising 16 individual grow rooms, is on track to reach its annualized full production run-rate of 75,000 kilograms by mid-2019. Pure Sunfarms is now moving forward on its plan to convert the nearly identical 1.1 million square foot Delta 2 ‘sister’ facility with the goal of at least doubling annual cannabis production to 150,000 kilograms and support its goal to be the high-quality, low-cost producer in Canada.

  • Wall Street Ratings for Cannabis Stocks Last Week
    Market Realist27 days ago

    Wall Street Ratings for Cannabis Stocks Last Week

    Cannabis Updates: New Listings, Price Action, and Ratings(Continued from Prior Part)Cannabis The cannabis sector (HMMJ) closed in the red last week. Let’s see how analysts are rating some of the major cannabis players and analyze the changes last

  • Cannabis Updates: New Listings, Price Action, and Ratings
    Market Realist27 days ago

    Cannabis Updates: New Listings, Price Action, and Ratings

    Cannabis Updates: New Listings, Price Action, and RatingsCannabis updateThe cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.

  • How Cannabis Companies’ Upside Potential Stacks Up
    Market Realistlast month

    How Cannabis Companies’ Upside Potential Stacks Up

    Why Did Cannabis Stocks Fall on April 15?(Continued from Prior Part)Cannabis stocks Cannabis stocks were deep in the red on April 15. The sector is known for high volatility. Stocks in the cannabis space are more volatile compared to broader

  • Why Did Cannabis Stocks Fall on April 15?
    Market Realistlast month

    Why Did Cannabis Stocks Fall on April 15?

    Why Did Cannabis Stocks Fall on April 15?Cannabis stocksCannabis stocks were broadly in the red on April 15. Charlotte’s Web Holdings (CWBHF) saw a negative price action of 5.8%. Looking at other stocks, Emerald Health Therapeutics (EMH), Supreme

  • ACCESSWIRElast month

    Three Cannabis Stocks with Budding Opportunities in 2019

    HOUSTON, TX / ACCESSWIRE / April 9, 2019 / Controversial or not, it's tough to ignore the cannabis boom. Just over the last two years, it's been responsible for transforming multi-billion-dollar industries, ...

  • GlobeNewswirelast month

    Emerald Health Therapeutics to Present at Investment Conferences in April

    OTCQX: EMHTF), a licensed producer of cannabis products for medical and recreational purposes, announced today that executives of the company will participate in multiple upcoming investment conferences.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec

    OTCQX: EMHTF) today announced that its Québec facility, Verdélite, has received its Standard Processing License from Health Canada. This license means that, in addition to Verdélite’s right to cultivate and sell cannabis flowers, it can now extract, manufacture, synthesize, test and sell next-generation cannabis products and will position Verdélite to launch these products in conjunction with the expected legalization of a broader spectrum of cannabis products in Canada in October 2019.

  • How Medical Marijuana Stocks Performed on April 4
    Market Realistlast month

    How Medical Marijuana Stocks Performed on April 4

    How Medical Marijuana Stocks Performed on April 4(Continued from Prior Part)Medical marijuana stocks The cannabis sector saw some weakness on April 4. The ETFMG Alternate Harvest ETF (MJ) saw a negative price action of 0.11%. Charlotte’s Web

  • Market Exclusivelast month

    Opportunities For Emerald Health Continue To Expand After Expansion Of Production Capacity

    A recent news release indicates that Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) will expand its market share in supplying cannabis. Notably, the firm intends to be the cannabis supplier for Société Québécoise du Cannabis (SQDC) after signing a letter of intent. In the letter, Emerald agreed to deliver the first shipment during Q2 2019. Emerald Health […]The post Opportunities For Emerald Health Continue To Expand After Expansion Of Production Capacity appeared first on Market Exclusive.

  • GlobeNewswire2 months ago

    Emerald Health Therapeutics Signs Letter of Intent to Supply Cannabis to Québec Market

    OTCQX: EMHTF) has signed a letter of intent to supply cannabis to the Société Québécoise du Cannabis (SQDC), Quebec's sole legal distributor of recreational cannabis. Under the agreement, Emerald will supply cannabis to the SQDC from its Québec-based Saint-Eustache facility, Verdélite, as well as from its 50%-owned joint venture, Pure Sunfarms, in Delta, BC. Emerald will fulfill its first supply order in Q2 2019. “Québec’s population of 8.4 million is a sizable market and we are pleased to be able to offer locally-grown, quality cannabis products to the adult-use consumers throughout the province,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald.

  • Market Exclusive2 months ago

    Emerald Health Fulfills Yukon Purchase Order, Alberta Supply Agreement

    Emerald Health Therapeutics (OTCMKTS:EMHTF) has announced that they have fulfilled their first Yukon Liquor Corporation cannabis purchase order and the signing of a sales agreement with Alberta Gaming Liquor and Cannabis. Emerald to supply five provinces They have also been registered officially by the Saskatchewan Liquor and Gaming Authority to supply the Saskatchewan market with […]The post Emerald Health Fulfills Yukon Purchase Order, Alberta Supply Agreement appeared first on Market Exclusive.